title: Recent developments in the subcutaneous ICD.
abstract: The subcutaneous implantable cardioverter-defibrillator (ICD) was developed as a simple device to reduce the morbidity of ICD therapy while providing a comparable reduction in sudden death from ventricular fibrillation. This review highlights the differences compared to the traditional ICD. It includes recent data on safety and efficacy, as well as best practices on screening and programming, and discusses expected future developments.
authors.affiliation: Division of Cardiology, University of Washington, Seattle, WA.
authors.forename: Mark E
authors.initials: ME
authors.lastname: Willcox
authors.affiliation: Division of Cardiology, University of Washington, Seattle, WA. Electronic address: jprutkin@cardiology.washington.edu.
authors.forename: Jordan M
authors.initials: JM
authors.lastname: Prutkin
authors.affiliation: Division of Cardiology, University of Washington, Seattle, WA.
authors.forename: Gust H
authors.initials: GH
authors.lastname: Bardy
mesh_terms: D016757:Death, Sudden, Cardiac / Q000209:etiology / Q000517:prevention & control*; D017147:Defibrillators, Implantable; D004059:Diffusion of Innovation; D004554:Electric Countershock / Q000009:adverse effects / Q000295:instrumentation* / Q000401:mortality; D006801:Humans; D061214:Patient Safety; D011474:Prosthesis Design; D011475:Prosthesis Failure; D019919:Prosthesis Implantation / Q000009:adverse effects / Q000379:methods* / Q000401:mortality; D012307:Risk Factors; D016896:Treatment Outcome; D014693:Ventricular Fibrillation / Q000175:diagnosis / Q000401:mortality / Q000503:physiopathology / Q000628:therapy*
keywords: Implantable cardioverter-defibrillator; Subcutaneous implantable cardioverter-defibrillator; Sudden cardiac death; Ventricular fibrillation